Passage Summary: A drug company director argues that vaccines aren't very profitable because you only buy them once, unlike other medicines you have to take over and over again.

Conclusion: Marketing vaccines is likely to be less profitable than marketing other pharmaceutical products.

Reasoning: Vaccines are typically administered to a patient only once, whereas other medicines for chronic illnesses are taken repeatedly, leading to higher sales volume for the latter.

Analysis: The director's argument hinges on the idea that 'frequency of use' is the primary driver of profit. To weaken this, we need to find a factor that could make vaccines highly profitable despite being one-time purchases. Perhaps the price per dose of a vaccine is significantly higher than a single dose of a chronic medication, or perhaps the sheer number of people receiving a vaccine outweighs the repeat customers for other drugs. Look for an answer that introduces a financial benefit of vaccines that the director ignored.